Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia.
Hart S, Goh KC, Novotny-Diermayr V, Tan YC, Madan B, Amalini C, Ong LC, Kheng B, Cheong A, Zhou J, Chng WJ, Wood JM.
Hart S, et al. Among authors: zhou j.
Blood Cancer J. 2011 Nov;1(11):e44. doi: 10.1038/bcj.2011.43. Epub 2011 Nov 11.
Blood Cancer J. 2011.
PMID: 22829080
Free PMC article.